MOLLY GUTHRIE

H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research.

H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.4541/S.2339 - The EARLY Act Reauthorization of 2025; a bill to reauthorize the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 H.R.8358/S.4318 - Breast Cancer Research Stamp Reauthorization Act; efforts to introduce a bill to amend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research H.R.3521/S.4440 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Comments related to a proposed rule on Excepted Fertility Benefits (CMS-9879-P) Comments in response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Efforts to introduce legislation related to the establishment of an interagency task force on breast cancer risk assessment tools Efforts related to the Office of Management and Budget Proposed Rule to revise the Guidance for Federal Financial Assistance

H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; a bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes H.R.9495 - Department of Defense Appropriations Act, 2027; a bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; a bill making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9770 - Continuing Appropriations Act, 2027; a bill to provide continuing FY2027 appropriations for federal agencies and extends various expiring programs and authorities FY27 appropriations related to funding for biomedical research, National Breast and Cervical Cancer Early Detection Program, cancer prevention and control, FDA funding, and related cancer services Comments related to Regulation for Federal Financial Assistance (OMB-2026-0034)

H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101/S.5004 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider

H.R.3037/S.1500 - Access to Breast Cancer Diagnosis Act; a bill to eliminate cost sharing for medically necessary diagnostic and supplemental breast imaging for patients with private insurance H.R.4101 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. S.1410 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer H.R.3521 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes Implementation of the Affordable Care Act and policies related to the extension of Advanced Enhanced Premium Tax Credits Comments related to the Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability proposed rule (CMS-9884-P)

H.R.4016 - Department of Defense Appropriations Act, 2026; a bill to make appropriations for the Department of Defense for the fiscal year ending September 30, 2026 H.R.3906 - Medical Research for Our Troops Act; a bill to amend the Full-Year Continuing Appropriations and Extensions Act, 2025 to restore amounts available for Defense Health Agency research, development, test, and evaluation, including Congressionally Directed Medical Research Programs.

H.R.2381/S.1866 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program H.R.3521 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes

H.R.842/S.339 - Medicare Multi-Cancer Early Detection Screening Coverage Act; a bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests Proposed waivers under Sections 1115 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to telehealth benefits and access for Medicare beneficiaries Policies related to the preservation of the structure and funding of Medicaid Activities related to feedback on the Selected Drug List for Initial Price Applicability Years (IPAYs) 2026 and 2027 Comments related to Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly

H.R.1968 - Full Year Continuing Appropriations and Extensions Act; a bill to provide continuing FY2025 appropriations for federal agencies and extends various expiring programs; all provisions including funding for the congressionally-directed medical research program, especially those relating to breast cancer

Efforts to reintroduce the Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program Policies related to sterile injectable medications shortages Comments related to Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts OIG-1124-N, 89 Fed. Reg. 93545 Policies related to PBM and drug cost transparency Efforts related to proposed reductions in force and rescission of the Richardson Waiver at the Department of Health and Human Services

H.R.8412 - Clinical Trial Modernization Act; a bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes. H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. S. 2140 - Patient Eligibility Restoration Act; a bill to amend the law relating to patent subject matter eligibility to establish that only specified subject matter (e.g., a natural process wholly independent of human activity) is ineligible for patenting. Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Comments related to draft Womens Preventive Services Initiative recommendations to Health Resources and Services Administration regarding screening for Breast Cancer Screening for Women at Average Risk and Patient Navigation Services for Breast and Cervical Cancer Screening Comments in response to Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice (FDA-2024-D-2052)

FY25 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670/ S.4638 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 3876/S .2323 - Access to Genetic Counselor Services Act of 2023; This bill provides for coverage under Medicare of genetic counseling services that are furnished by genetic counselors. Covered services include those services, as well as incidental services and supplies, that would otherwise be covered under Medicare if provided by a physician. H.R.8702/S.4532 - Improving Seniors Timely Access to Care Act - a bill to establish an electronic prior authorization standard to streamline approvals, reduce the amount of time a health plan is allowed to consider a prior authorization request, require MA plans to report on their use of prior authorization and the rate of approvals and denials, and encourage MA plans to adopt policies that adhere to evidence-based guidelines. H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act ; would ensure Medicare beneficiaries receive prompt care and services from pharmacists to prevent, diagnose, and treat common infectious diseases. S. 3892 - Community Health Worker Access Act; a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs. Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to PBM reform Policies related to the implementation of the Inflation Reduction Act

H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 FY25 Labor, HHS, and Education appropriation bill related to funding for biomedical research, social determinants of health, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging Policies related to use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening Policies related to supplemental and diagnostic breast imaging

FY25 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670/ S.4638 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 3876/S .2323 - Access to Genetic Counselor Services Act of 2023; This bill provides for coverage under Medicare of genetic counseling services that are furnished by genetic counselors. Covered services include those services, as well as incidental services and supplies, that would otherwise be covered under Medicare if provided by a physician. H.R.8702/S.4532 - Improving Seniors Timely Access to Care Act - a bill to establish an electronic prior authorization standard to streamline approvals, reduce the amount of time a health plan is allowed to consider a prior authorization request, require MA plans to report on their use of prior authorization and the rate of approvals and denials, and encourage MA plans to adopt policies that adhere to evidence-based guidelines. H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act ; would ensure Medicare beneficiaries receive prompt care and services from pharmacists to prevent, diagnose, and treat common infectious diseases. S. 3892 - Community Health Worker Access Act; a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs. Women's Health and Cancer Rights Act (WHCRA) - a federal law that provides protections to patients who choose to have breast reconstruction in connection with a mastectomy. Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policies related to PBM reform Policies related to the implementation of the Inflation Reduction Act Comments in response to Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, including the Hospital Inpatient Quality Reporting Program; Health and Safety Standards for Obstetrical Services in Hospitals and Critical Access Hospitals; Prior Authorization; Requests for Information; Medicaid and CHIP Continuous Eligibility; Medicaid Clinic Services Four Walls Exceptions; Individuals Currently or Formerly in Custody of Penal Authorities; Revision to Medicare Special Enrollment Period for Formerly Incarcerated Individuals; and All-Inclusive Rate Add-On Payment for High-Cost Drugs Provided by Indian Health Service and Tribal Facilities (CMS-1809-P, RIN 0938-AV35)

H.R. 9029/S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 FY25 Labor, HHS, and Education appropriation bill related to funding for biomedical research, social determinants of health, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging Policies related to use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening Policies related to report language on the implementation of the Medicare Prescription Payment Plan Policies related to supplemental and diagnostic breast imaging

H.R. 2851/ S. 2464 - Access to Breast Cancer Diagnosis Act of 2023; bill to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations H.R. 6301/ S. 2039 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. H.R. 830/S. 1375 -Help Ensure Lower Patient (HELP) Copays Act; bill requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements. Specifically, plans must apply third-party payments, financial assistance, discounts, product vouchers, and other reductions in out-of-pocket expenses toward the requirements. H.R. 2630/S. 652 -Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023; bill expanding exception for stand-alone telehealth benefits plans from certain requirements that generally apply to private health insurance plans under the Patient Protection and Affordable Care Act; under the bill employers may offer stand-alone telehealth benefits to all employees including those who are eligible for enrollment in their employers group health plan H.R. 2868 - Association Health Plans Act; a bill to amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes S.4767 - Insurance Fraud Accountability Act; a bill to amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes H.J. Res. 181- Congressional Review Act resolution to stop Biden-Harris rule limiting access to Association Health Plans (AHPs) S. 8 - Improving Health Insurance Affordability Act of 2023; a bill to expand the eligibility of taxpayers for the refundable tax credit for coverage under a qualified health plan and increases cost-sharing subsidies under the Patient Protection and Affordable Care Act H.R. 1692 - Health Care Affordability Act of 2023; a bill to revise the tax credit for health care premium assistance to expand the eligibility of low-income taxpayers for such credit and reduce the cost of health care premiums H.R. 9774/ S. 5194 - Health Care Affordability Act; a bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan Administration actions necessary to reduce out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging Implementation of the Affordable Care Act and coverage of preventive services with no cost-sharing Issues related to regulation of short-term limited duration plans Issues related to prescription drug affordability for patients Policies regarding White House Cancer Moonshot implementation Policies related to copay accumulator and adjustor programs Comments related to the 2026 Notice on Benefit and Payment Parameters

FY25 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670/ S.4638 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

H.R. 2851/ S. 2464 - Access to Breast Cancer Diagnosis Act of 2023; bill to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations H.R. 6301/ S. 2039 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. H.R. 830/S. 1375 -Help Ensure Lower Patient (HELP) Copays Act; bill requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements. Specifically, plans must apply third-party payments, financial assistance, discounts, product vouchers, and other reductions in out-of-pocket expenses toward the requirements. H.R. 2630/S. 652 -Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023; bill expanding exception for stand-alone telehealth benefits plans from certain requirements that generally apply to private health insurance plans under the Patient Protection and Affordable Care Act; under the bill employers may offer stand-alone telehealth benefits to all employees including those who are eligible for enrollment in their employers group health plan H.R. 2868 - Association Health Plans Act; a bill to amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes Administration actions necessary to reduce out-of-pocket costs for medically necessary diagnostic and supplemental breast imaging Implementation of the Affordable Care Act and coverage of preventive services with no cost-sharing Issues related to regulation of short-term limited duration plans Issues related to prescription drug affordability for patients Policies regarding White House Cancer Moonshot implementation Policies related to copay accumulator and adjustor programs Comments in response to House Education & Workforce RFI on Employee Retirement Income Security Act (ERISA) Comments related to the 2026 Notice on Benefit and Payment Parameters Efforts to introduce the Broker Accountability Act

H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 3876/S .2323 - Access to Genetic Counselor Services Act of 2023; This bill provides for coverage under Medicare of genetic counseling services that are furnished by genetic counselors. Covered services include those services, as well as incidental services and supplies, that would otherwise be covered under Medicare if provided by a physician. H.R.8702/S.4532 - Improving Seniors Timely Access to Care Act - a bill to establish an electronic prior authorization standard to streamline approvals, reduce the amount of time a health plan is allowed to consider a prior authorization request, require MA plans to report on their use of prior authorization and the rate of approvals and denials, and encourage MA plans to adopt policies that adhere to evidence-based guidelines. H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act ; would ensure Medicare beneficiaries receive prompt care and services from pharmacists to prevent, diagnose, and treat common infectious diseases. S. 3892 - Community Health Worker Access Act; a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs. Women's Health and Cancer Rights Act (WHCRA) - a federal law that provides protections to patients who choose to have breast reconstruction in connection with a mastectomy. Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policies related to PBM reform Policies related to the implementation of the Inflation Reduction Act Comments in response to RFI: Medicare Program: Request for Information on Medicare Advantage Data (CMS-4207-NC)

H.R. 549/S. 663 -Metastatic Breast Cancer Access to Care Act; a bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act ; would ensure Medicare beneficiaries receive prompt care and services from pharmacists to prevent, diagnose, and treat common infectious diseases. S. 3892 - Community Health Worker Access Act; a bill to amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs. H.R. 3876/S .2323 - Access to Genetic Counselor Services Act of 2023; This bill provides for coverage under Medicare of genetic counseling services that are furnished by genetic counselors. Covered services include those services, as well as incidental services and supplies, that would otherwise be covered under Medicare if provided by a physician. Comments Related to OIG Solicitation New and Modified Safe Harbors and Special Fraud Alerts OIG-1123-N, 88 Fed. Reg. 84116 requesting permission for sponsors of clinical trials targeting cancer or other life-threatening diseases or conditions to cover certain indirect costs incurred by clinical trial participants. Comments Related to CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments related to processes for assessing compliance with Mental Health Parity and Addition Equity in Medicaid and CHIP Comments related to Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Comments RE: Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025 Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policies related to PBM reform Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Policies related to the implementation of the Inflation Reduction Act Policies related to the implementation of the Lymphedema Treatment Act

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 2243 - Palliative Care and Hospice Education and Training Act; a bill amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care. S. 2140 - Patient Eligibility Restoration Act; a bill to amend the law relating to patent subject matter eligibility to establish that only specified subject matter (e.g., a natural process wholly independent of human activity) is ineligible for patenting. Comments related to healthcare affordability Efforts related to breast screening recommendations by the United States Preventative Services Taskforce Efforts to preserve protections in the Affordable Care Act (ACA) for LGBTQ+ patients Policies related to ICD-10 codes for inflammatory breast cancer Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

FY24 Labor, HHS, and Education appropriation bill related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging FY25 Labor, HHS, and Education appropriation bill related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging FY25 Presidents Budget Proposal related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging Policies related to transparent use of artificial intelligence, via patient notification, and validation of its use, scaling and outcomes in breast cancer screening Policies related to supplemental and diagnostic breast imaging

H.R. 2851/S. 2464 - Access to Breast Cancer Diagnosis Act of 2023; bill to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations S. 2039/H.R. 6301 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. H.R. 830/S. 1375 -Help Ensure Lower Patient (HELP) Copays Act; bill requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements. Specifically, plans must apply third-party payments, financial assistance, discounts, product vouchers, and other reductions in out-of-pocket expenses toward the requirements. H.R. 2630/S. 652 -Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023; bill expanding exception for stand-alone telehealth benefits plans from certain requirements that generally apply to private health insurance plans under the Patient Protection and Affordable Care Act; under the bill employers may offer stand-alone telehealth benefits to all employees including those who are eligible for enrollment in their employers group health plan H.R. 2868 - Association Health Plans Act; a bill to amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes H.R. 2813 - Self-Insurance Protection Act; a bill to amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to exclude from the definition of health insurance coverage certain medical stop-loss insurance obtained by certain plan sponsors of group health plans, and for other purposes. H.R. 3799 - Custom Health Option and Individual Care Expense (CHOICE) Arrangement Act; a bill to provide statutory authority for regulations that allow employers to offer individual coverage health reimbursement arrangements (ICHRAs) H.R.1843/S.1001 - Telehealth Expansion Act of 2023; a bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules Comments regarding US District Court Decision on 2021 Notice on Benefit and Payment Parameters Administrative actions necessary to reduce out-of-pocket costs for medically-necessary diagnostic breast imaging Implementation of the Affordable Care Act and coverage of preventive services with no cost-sharing Issues related to regulation of short-term limited duration plans Issues related to prescription drug affordability for patients Policies regarding White House Cancer Moonshot implementation

H.R. 549/S. 663 -Metastatic Breast Cancer Access to Care Act; a bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. The Modernizing and Ensuring PBM Accountability (MEPA) Act - a bill to enhance accountability for pharmacy benefit managers (PBMs), address misaligned incentives that contribute to high prescription drug costs for patients, prevent spread pricing within the Medicaid program, improve access to pharmacies, and increase oversight of the prescription drug supply chain Efforts to introduce the Community Health Worker Access Act to improve access to Community Health Worker services for Medicare and Medicaid enrollees Policies related to sterile injectable medications shortages Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Policies related to the implementation of the Inflation Reduction Act Policies related to the implementation of the Lymphedema Treatment Act

FY24 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

FY24 Labor, HHS, and Education appropriation bill related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging FY25 Presidents Budget Proposal related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging House Budget Committee RFI related to the Health Care Task Force with the aim of examining the primary factors influencing healthcare expenditure and exploring solutions to enhance health outcomes while reducing debt curve.

H.R. 549/S. 663 -Metastatic Breast Cancer Access to Care Act; a bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. The Modernizing and Ensuring PBM Accountability (MEPA) Act - a bill to enhance accountability for pharmacy benefit managers (PBMs), address misaligned incentives that contribute to high prescription drug costs for patients, prevent spread pricing within the Medicaid program, improve access to pharmacies, and increase oversight of the prescription drug supply chain Comments in response to CMS Notice of Proposed Rulemaking Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) Comments in response to CMS Proposed Calendar Year (CY) 2024 Home Health (HH) Prospective Payment System Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin Items and Services; Hospice Informal Dispute Resolution and Special Focus Program Requirements, Certain Requirements for Durable Medical Equipment Prosthetics and Orthotics Supplies; and Provider and Supplier Enrollment Requirements (CMS-1780-P) Comments in response to Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Payment for Intensive Outpatient Services in Rural Health Clinics, Federally Qualified Health Centers, and Opioid Treatment Programs; Hospital Price Transparency; Changes to Community Mental Health Centers Conditions of Participation, Proposed Changes to the Inpatient Prospective Payment System Medicare Code Editor; Rural Emergency Hospital Conditions of Participation Technical Correction Comments in response to Medicare and Medicaid Programs; CY 2024 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program Comments in response to Solicitation of Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025 Comments in anticipation of the release of the CY25 Notice on Benefit and Payment Parameters Policies related to sterile injectable medications shortages Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Policies related to the implementation of the Inflation Reduction Act Policies related to the implementation of the Lymphedema Treatment Act

FY24 Labor, HHS, and Education appropriation bill related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging FY25 Presidents Budget Proposal related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging

H.R. 2851/S. 2464 - Access to Breast Cancer Diagnosis Act of 2023; bill to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations S. 2039 - Cancer Drug Parity Act; a bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. H.R. 830/S. 1375 -Help Ensure Lower Patient (HELP) Copays Act; bill requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements. Specifically, plans must apply third-party payments, financial assistance, discounts, product vouchers, and other reductions in out-of-pocket expenses toward the requirements. H.R. 2630/S. 652 -Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023; bill expanding exception for stand-alone telehealth benefits plans from certain requirements that generally apply to private health insurance plans under the Patient Protection and Affordable Care Act; under the bill employers may offer stand-alone telehealth benefits to all employees including those who are eligible for enrollment in their employers group health plan H.R. 2868 - Association Health Plans Act; a bill to amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes H.R. 2813 - Self-Insurance Protection Act; a bill to amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to exclude from the definition of health insurance coverage certain medical stop-loss insurance obtained by certain plan sponsors of group health plans, and for other purposes. H.R. 3799 - Custom Health Option and Individual Care Expense (CHOICE) Arrangement Act; a bill to provide statutory authority for regulations that allow employers to offer individual coverage health reimbursement arrangements (ICHRAs) Comments in response to the Request for Information Regarding Medical Payment Products (CMS-2023-0106) Comments in response to Short-Term, Limited-Duration Insurance; Independent, Noncoordinated Excepted Benefits Coverage; Level-Funded Plan Arrangements; and Tax Treatment of Certain Accident and Health Insurance (CMS-9904-P) Administrative actions necessary to reduce out-of-pocket costs for medically-necessary diagnostic breast imaging Implementation of the Affordable Care Act and coverage of preventive services with no cost-sharing Issues related to regulation of short-term limited duration plans Issues related to prescription drug affordability for patients Policies regarding White House Cancer Moonshot implementation

FY24 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

FY24 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024; a bill which authorizes FY2024 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, military construction, and the national security programs of the Department of Energy

H.R. 2916/S. 1840 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2023; bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 H.R. 1092/S. 562 -Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act; requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act; To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 4363/S. 2213 - Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes. S. 1339 - Pharmacy Benefit Manager Reform Act; bill establishes various requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans Efforts to reintroduce legislation which requires the Department of Health and Human Services (HHS) to take a series of actions relating to palliative-care training known as the Palliative Care and Hospice Education and Training Act Comments regarding the nomination and confirmation of new National Institutes of Health Director Comments in response to a Congressional Request for Information regarding the role and mission of the Centers for Disease Control and Prevention Comments in response to draft recommendations on breast cancer screening release by the United States Preventative Services Taskforce Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to the implementation of the National Cancer Institutes National Cancer Plan Policies related to sterile injectable medications shortages Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Policies related to genetic counseling and testing Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to reforms to the United States Preventative Services Taskforce

H.R. 549/S. 663 -Metastatic Breast Cancer Access to Care Act; a bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings H.R. 1780/S. 642 - Finn Sawyer Access to Cancer Testing Act; bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. H.R. 2407/S. 2085 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. H.R. 3086 - Find It Early Act; a bill to provide for health coverage with no cost-sharing for additional breast screenings for certain individuals at greater risk for breast cancer. H.R. 4189/S. 2016 - Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes. Comments in response to the Medicare Drug Price Negotiation Program guidance (CMS-10847) Comments in response to notice on proposed rulemaking on Medicaid and Childrens Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality (CMS-2439-P)Medicare coverage policy for drugs and drug pricing and pharmacy services Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding and the process for redetermination of Medicaid eligibility Policies related to the imposition of work requirements within the Medicaid program Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Policies related to the implementation of the Inflation Reduction Act Policies related to the implementation of the Lymphedema Treatment Act

FY24 Labor, HHS, and Education appropriation bill related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging FY25 Presidents Budget Proposal related to funding for biomedical research, NBCCEDP, cancer prevention and control, and related cancer services and report language related to access to supplemental and diagnostic breast imaging H.R. 277/S. 526 -Regulation from the Executive in Need of Scrutiny Act; a bill to amend chapter 8 of title 5, United States Code, to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. H.R. 3746 - Fiscal Responsibility Act of 2023; a bill which increases the federal debt limit, establishes new discretionary spending limits, rescinds unobligated funds, expands work requirements for federal programs, and modifies other requirements related to the federal budget process

H.R. 549/S. 663 -Metastatic Breast Cancer Access to Care Act; a bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 1526/S. 765 -Reducing Hereditary Cancer Act of 2023; bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings Comments in response to proposed 2024 Notice of Benefit and Payment Parameters [CMS-9899-P] Comments in response to proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges (CMS-0057-P) Comments in response to Request for Information on Essential Health Benefits (RFI-CMS-9898-NC) Medicare coverage policy for drugs and drug pricing and pharmacy services Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicaid unwinding, the process for redetermination of Medicaid eligibility Policy related to medical billing for breast reconstruction surgery called DIEP flap, a type of natural tissue breast reconstruction that uses non-breast tissue to replace breast tissue Policies related to the implementation of the Inflation Reduction Act Policies related to the implementation of the Lymphedema Treatment Act

FY24 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer

Efforts to reintroduce legislation to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Efforts to reintroduce legislation to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. H.R. 830 -Help Ensure Lower Patient (HELP) Copays Act; bill requires health insurance plans to apply certain payments made by, or on behalf of, a plan enrollee toward a plan's cost-sharing requirements. Specifically, plans must apply third-party payments, financial assistance, discounts, product vouchers, and other reductions in out-of-pocket expenses toward the requirements. S. 652 -Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Implementation of the Affordable Care Act and coverage of preventive services with no cost-sharing Policies related to insurance coverage and COVID-19 Issues related to regulation of short-term limited duration plans Issues related to prescription drug affordability for patients Polices regarding White House Cancer Moonshot implementation Comments in Response to HHS Office of Inspector General solicitation of proposals for new and modified safe harbors and special fraud alerts (OIG-1122-N)

H.R. 2617 - Consolidated Appropriations Act of 2023; related to funding for biomedical research, NBCCEDP, social determinants of health programs, consumer assistance programs, and related cancer services and report language related to genetic counseling and testing H.R. 2617 - Consolidated Appropriations Act of 2023; FY2023 Defense appropriations related to funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer Policies related to development of the Advanced Research Projects Agency for Health

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 -Medicare Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography including preserving Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure S. 2327 - Seniors Prescription Drug Relief Act; a bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D H.R. 3173/S. 3018 - Improving Seniors Timely Access to Care Act; a bill which establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans H.R. 7213, Equitable Community Access to Pharmacist Services Act; a bill to provide pharmacy reimbursement for COVID-19-related and future emergency services. H.R. 9505, Find It Early Act; a bill to provide for health coverage with no cost-sharing additional breast screenings for certain individuals Comments regarding the temporary increase in federal medical assistance percentage (FMAP) in response to the COVID-19 Public Health Emergency (PHE) (CMS-9912-N) Comments in response to the Medicaid Eligibility and Enrollment NPRM (CMS-2421-P) Comments in response to the RFI regarding National Directory of Healthcare Providers & Services (CMS-0058-NC) Comments in response to the RFI regarding accessing healthcare and related challenges, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency (PHE) Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024 Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding, state incentives, and federal efforts for for Medicaid expansion Coverage for telemedicine in Medicare

H.R. 2617 - Consolidated Appropriations Act of 2023; FY 2023 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023

H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagement, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations H.R. 6584 - Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes. S. 3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats, (PREVENT) and Pandemics Act; a bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics. H.R. 7845 NIH Clinical Trial Diversity Act; a bill to direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes. H.R. 8185/S. 4440 - Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2023 through 2027 S. 4260 - Palliative Care and Hospice Education and Training Act; a bill to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools, social work schools, and other programs, including physician assistant education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative medicine. H.R. 7667/S. 4348 - Food and Drug Amendments of 2022; a bill to reauthorize Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices. H.R. 9565/S. 5295- Comprehensive Cancer Survivorship Act; a bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivors background, or forthcoming survivorship needs, and for other purposes. Policies related to telehealth Policies to increase clinical trial diversity and access for underrepresented populations Policies related to genetic counseling and testing Policies related to cancer survivorship Policies related to PBM and drug cost transparency Policies related to the reauthorization of FDA User Fee Agreements Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 Policies related to the implementation of the Mammography Quality Standards Act Policies related to administration actions necessary in breast imaging and breast cancer diagnosis Comments regarding a request for information on establishing a National Directory of Healthcare Providers and Services

H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography H.R. 5769/S. 1067 - Access to Breast Cancer Diagnosis Act; bill to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging H.R. 2163/S. 464 - Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 4385/S.3080 - Cancer Drug Parity Act; bill to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. H.R. 5376 - Inflation Reduction Act of 2022; a budget reconciliation bill which included provisions to continue subsidies on private insurance premiums, address out of pocket costs in Medicare Part D, and more H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act; a bill to amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 7045/S. 3796 - Closing Health Coverage Gaps for Public Servants Act; a bill to eliminate the opt-out for nonfederal governmental health plans, including the opt-out for coverage for full mastectomy and reconstruction care Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the Affordable Care Act Policies regarding White House Cancer Moonshot implementation Public and private insurance adjustments and other policy changes due to the COVID-19 emergency, including those impacting the immunocompromised populations S. 942 - No Junk Plans Act; bill to overturn previous administration rule expanding non-comprehensive health insurance plans that dont have to provide healthcare coverage for people with pre-existing conditions S. 1002 - Junk Plan Accountability and Disclosure Act; a bill which establishes requirements for certain noncomprehensive health insurance coverage and provides for additional outreach activities to increase enrollment in qualified health plans Policies related to co-pay assistance programs Policies related to the extension of Advanced Premium Tax Credits provided by the American Rescue Plan Comments on future rulemaking for the 2024 Notice on Benefit and Payment Parameters

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 -Medicare Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography including preserving Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure S. 2327 - Seniors Prescription Drug Relief Act; a bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D H.R. 3173/S. 3018 - Improving Seniors Timely Access to Care Act; a bill which establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans H.R. 5376 - Inflation Reduction Act of 2022; a budget reconciliation bill which included provisions to continue subsidies on private insurance premiums, address out of pocket costs in Medicare Part D, and more H.R. 7213, Equitable Community Access to Pharmacist Services Act; a bill to provide pharmacy reimbursement for COVID-19-related and future emergency services. Comments in response to CMS Proposed Rule on CY 2023 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System (CMS 1772-P) Comments in response to CMS Request for Information on Medicare Advantage (CMS-4203-NC ) Comments in response to CY2023 Medicare Physician Fee Schedule (CMS-1770-P) Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024 Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding, state incentives, and federal efforts for for Medicaid expansion Coverage for telemedicine in Medicare

FY 2023 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; a bill to authorize Department of Defense activities and programs for FY 2023

FY2023 Labor, HHS, and Education appropriations bill related to funding for biomedical research, NBCCEDP, social determinants of health programs, consumer assistance programs, and related cancer services and report language related to genetic counseling and testing FY2023 Defense appropriations bill related to funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc Policies related to development of the Advanced Research Projects Agency for Health Policies related to Paid Family and Medical leave

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 -Medicare Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography including preserving Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure S. 2327 - Seniors Prescription Drug Relief Act; a bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D H.R. 3173/S. 3018 - Improving Seniors Timely Access to Care Act; a bill which establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans H.R. 7213, Equitable Community Access to Pharmacist Services Act; a bill to provide pharmacy reimbursement for COVID-19-related and future emergency services. Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding, state incentives, and federal efforts for for Medicaid expansion Coverage for telemedicine in Medicare Comments in response to CMS Request for Information on Access to Coverage and Care in Medicaid and Chip Issues related to the upcoming Notice on Benefit and Payment Parameters for FY2024

FY2023 Labor, HHS, and Education appropriations bill related to funding for biomedical research, NBCCEDP, social determinants of health programs, consumer assistance programs, and related cancer services and report language related to genetic counseling and testing FY2023 Defense appropriations bill related to funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer Supplemental appropriations for COVID-19-related relief, the production of monoclonal antibodies, availability of testing, etc Policies related to development of the Advanced Research Projects Agency for Health Policies related to Paid Family and Medical leave

H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography H.R. 5769/S. 1067 - Access to Breast Cancer Diagnosis Act; bill to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging H.R. 2163/S. 464 - Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 4385/S.3080 - Cancer Drug Parity Act; bill to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act; a bill to amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 7045/S. 3796 - Closing Health Coverage Gaps for Public Servants Act; a bill to eliminate the opt-out for nonfederal governmental health plans, including the opt-out for coverage for full mastectomy and reconstruction care Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Issues related to regulation of short-term limited duration plans Implementation of the No Surprises Act Implementation of the Affordable Care Act Policies regarding White House Cancer Moonshot implementation Public and private insurance adjustments and other policy changes due to the COVID-19 emergency, including those impacting the immunocompromised populations S. 942 - No Junk Plans Act; bill to overturn previous administration rule expanding non-comprehensive health insurance plans that dont have to provide healthcare coverage for people with pre-existing conditions S. 1002 - Junk Plan Accountability and Disclosure Act; a bill which establishes requirements for certain noncomprehensive health insurance coverage and provides for additional outreach activities to increase enrollment in qualified health plans Policies related to co-pay assistance programs Policies related to the extension of Advanced Premium Tax Credits provided by the American Rescue Plan Comments on the Affordability of Employer Coverage for Family Members of Employees; IRS-2022-0006

H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagment, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations H.R. 6584 - Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; a bill to direct the Commissioner of Food and Drugs to amend certain regulations to increase clinical trial diversity, and for other purposes. S. 3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats, (PREVENT) and Pandemics Act; a bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics. Efforts to introduce a bill regarding clinical trial diversity nicknamed the The Clinical Trial Diversity Act Efforts to introduce a bill to reauthorize the National Breast and Cervical Cancer Early Detection Program Comments regarding the confirmation of Robert Califf as FDA Commissioner Policies related to telehealth Policies related to COVID-19 vaccination and monoclonal antibody distribution Policies to increase clinical trial diversity and access for underrepresented populations Policies related to genetic counseling and testing Policies related to reauthorization of user fees at the Food and Drug Administration Policies related to cancer survivorship Policies related to PBM and drug cost transparency Comments regarding Requests for Information from the Healthy Futures Task Force Review of FDA Draft Guidance for Industry, including Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products.

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 -Medicare Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography including preserving Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure S. 2327 - Seniors Prescription Drug Relief Act; a bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D H.R. 3173/S. 3018 - Improving Seniors Timely Access to Care Act; a bill which establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans H.R. 7213, Equitable Community Access to Pharmacist Services Act; a bill to provide pharmacy reimbursement for COVID-19-related and future emergency services. Comments regarding the Notice on Benefit and Payment Parameters for FY2023 CMS-2021-0196 Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding, state incentives, and federal efforts for for Medicaid expansion Coverage for telemedicine in Medicare Policies related to the Radiation Oncology Alternative Payment Model Comments related to the design of an Advanced Projects Research Agency for Health

FY 2022 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 4350/S. 1605 - National Defense Authorization Act for Fiscal Year 2022; a bill to authorize Department of Defense activities and programs for FY 2022

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 -Medicare Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 4414 - Cancer Care Planning and Communications Act of 2021; a bill to provide for Medicare coverage and payment of cancer care planning and coordination services for individuals who are diagnosed with or treated for cancer, including the development of treatment plans, follow-up care, and any necessary revisions H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography including preserving Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure S. 2327 - Seniors Prescription Drug Relief Act; a bill to amend title XVIII of the Social Security Act to provide for a Medicare part D modernization redesign and to establish a monthly out-of-pocket cost sharing maximum for enrollees who incur a significant portion of costs towards the annual out-of-pocket threshold under Medicare part D H.R. 3173/S. 3018 - Improving Seniors Timely Access to Care Act; a bill which establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding, state incentives, and federal efforts for for Medicaid expansion Coverage for telemedicine in Medicare Policies related to the Radiation Oncology Alternative Payment Model Comments regarding the recission of the Indexed Price Concession Model/ Most Favored Nation Model for Medicare Part B drugs (CMS-2018-0132) Comments related to the design of an Advanced Projects Research Agency for Health

FY 2022 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 4350/S. 1605 - National Defense Authorization Act for Fiscal Year 2022; a bill to authorize Department of Defense activities and programs for FY 2022

H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 5030/S.2706 - DIVERSE Trials Act; A bill to require FDA to issue guidance on decentralized clinical trials to promote meaningful demographic/geographic diversity in patient engagment, expand reporting by laboratories that test for and diagnose COVID-19, and require a study on data collection and data sharing during public health emergencies H.R. 6000 - Cures 2.0 Act; a comprehensive healthcare and biomedical research bill H.R. 4794/S. 2533 - Making Advances in Mammography and Medical Options for Veterans Act; a bill to improve mammography services furnished by the Department of Veterans Affairs H.R. 4571/S. 2102 - Supporting Expanded Review for Veterans in Combat Environments (SERVICE) Act of 2021; a bill to expand eligibility for Veterans Health Administration mammography screenings to veterans who served in certain locations during specified periods, including those who were exposed to toxic substances at such locations Policies related to the design of an Advanced Projects Research Agency for Health Comments related to the Department of Health and Human Services Strategic Plan FY 2018-2022 Comments related to the Department of Health and Human Services Proposed Repeal of HHS Rules on Guidance, Enforcement, and Adjudication Procedures (RIN 0991-AC29) Comments regarding the repeal of final rule entitled Securing Updated and Necessary Statutory Evaluations Timely (SUNSET rule) Comments regarding the nomination of Robert Califf as FDA Commissioner Policies related to telehealth Policies related to COVID-19 vaccination distribution Policies to increase clinical trial diversity and access for underrepresented populations Policies related to cancer survivorship Policies related to PBM and drug cost transparency

FY2022 Labor, HHS, and Education appropriations bill related to funding for biomedical research, NBCCEDP, social determinants of health programs, and related cancer services and report language related to metastatic breast cancer FY2022 Defense appropriations bill related to funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 869/S. 289 - Research Investment to Spark the Economy Act of 2021; bill to authorize federal agencies to provide support for research regarding COVID-19 or research disrupted by the COVID-19 pandemic H.R. 5376 - Build Back Better Act, efforts to influence policies included in the Build Back Better Act Implementation of the American Rescue Plan

H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. Efforts to introduce a comprehensive healthcare and biomedical research bill nicknamed Cures 2.0 Comments to Food and Drug Administration on Core Patient-Reported Outcomes in Cancer Clinical Trials: Draft Guidance for Industry (Docket No. FDA-2020-D-2303) Comments to Department of Health and Human Services on an RFI Regarding Reporting on Pharmacy Benefits and Prescription Drug Costs, File Code CMS-9905-NC Comments to Office of Management and Budget on health equity Comments related to the design of an Advanced Projects Research Agency for Health Policies related to telehealth Policies related to COVID-19 vaccination distribution Policies to increase clinical trial diversity and access for underrepresented populations Policies related to Paid Family and Medical leave

FY 2022 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer

H.R. 4612/S. 2412 - Protecting Access to Lifesaving Screenings Act of 2021; a bill to make a series of changes relating to health insurance coverage of screening mammography S. 1067 - Access to Breast Cancer Diagnosis Act; bill to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging H.R. 2163/S. 464 - Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes H.R. 4385 - Cancer Drug Parity Act; bill to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. Implementation of the No Surprises Act including comments related to PRA Listings for the Implementation of the No Surprises Act (CMS-10780 & CMS-10779) Implementation of the Affordable Care Act Public and private insurance adjustments and other policy changes due to the COVID-19 emergency, including those impacting the immunocompromised populations No Junk Plans Act; bill to overturn previous administration rule expanding non-comprehensive health insurance plans that dont have to provide healthcare coverage for people with pre-existing conditions Policies related to co-pay assistance programs

H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. S Res 253 - Resolution supports the designation of May 2021 as National Cancer Research Month Policies related to telehealth Policies related to COVID-19 vaccination distribution Policies to increase clinical trial diversity and access for underrepresented populations

H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. H.R. 1946/S. 1873 - Multi-Cancer Early Detections Screening and Coverage Act; bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening test H.R. 3183/S. 1312 - Metastatic Breast Cancer Access to Care Act; bill to exempt individuals with metastatic breast cancer from certain waiting periods for disability insurance benefits under the Old-Age, Survivors, and Disability Insurance program and related Medicare coverage H.R. 2903/S. 1512 - CONNECT for Health Act; a bill to expand the use of telehealth and remote patient monitoring services in Medicare H.R. 3087/S. 2051 - Breast Cancer Patient Equity Act; a bill to provide for Medicare coverage of custom fabricated breast prostheses H.R. 3517/S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act; a bill to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement H.R. 3630/S. 1315 - Lymphedema Treatment Act; bill to include certain lymphedema compression treatment items as covered durable medical equipment under Medicare following the surgical removal of the breast (i.e., a mastectomy), including replacements of such prostheses H.R. 4110 - Reducing Hereditary Cancer Act of 2021; a bill to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer H.R. 3173 - Improving Seniors' Timely Access to Care Act; bill establishes several prohibitions, requirements, and standards relating to prior authorization processes under Medicare Advantage (MA) plans Medicare coverage policy for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Proposed waivers under Sections 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to funding for Medicaid expansion Coverage for telemedicine in Medicare

FY2022 Labor, HHS, and Education appropriations bill related to funding for biomedical research, NBCCEDP, social determinants of health programs, NCCDPHP, consumer assistance programs, and related cancer services and report language related to metastatic breast cancer FY2022 Defense appropriations bill related to funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer H.R. 869/S. 289 - Research Investment to Spark the Economy Act of 2021; bill to authorize federal agencies to provide support for research regarding COVID-19 or research disrupted by the COVID-19 pandemic S. 674 - Public Health Infrastructure Saves Lives Act; a bill to authorize funding to improve public health systems through grants by CDC to state, territorial, local, and tribal health departments Implementation of the American Rescue Plan

FY 2022 Funding and issues pertaining to the congressionally-directed medical research program, especially those relating to breast cancer

FY22 funding and issues pertaining to the congressionally-directed medical research program, especially those relating the breast cancer

FY2022 funding for biomedical research, NBCCEDP, social determinants of health programs, and related cancer services FY2022 Labor, HHS, and Education appropriations report language related to metastatic breast cancer H.R. 869/S. 289 - Research Investment to Spark the Economy Act of 2021; bill to authorize federal agencies to provide support for research regarding COVID-19 or research disrupted by the COVID-19 pandemic S. 571 - Public Health Funding Prevents Pandemics Act; bill to fund the Prevention and Public Health Fund and reaffirm the importance of prevention in the United States healthcare system Comments to White House on clinical trial continuation, health disparities, federal research investment, funding for NBCCEDP, SSDI and Medicare waiting periods, access to diagnostic imaging, and telehealth.

S. 1067 - Access to Breast Cancer Diagnosis Act; bill to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging S. 1002 - Junk Plan Accountability Disclosure Act; bill to prohibit false or misleading advertising for health insurance coverage, require warnings and reporting with respect to noncomprehensive health plans, encourage enrollment in health plans, and for other purposes S. 464 - Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes S. 779 - Protecting Americans with Pre-Existing Conditions Act of 2021; bill to provide that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. Comments to White House on clinical trial continuation, health disparities, federal research investment, funding for NBCCEDP, SSDI and Medicare waiting periods, access to diagnostic imaging, and telehealth. Efforts to reintroduce Cancer Drug Parity Act; bill to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. Implementation of the Affordable Care Act Public and private insurance adjustments and other policy changes due to the COVID-19 emergency, including those impacting the immunocompromised populations No Junk Plans Act; bill to overturn previous administration rule expanding non-comprehensive health insurance plans that dont have to provide health care coverage for people with pre-existing conditions Policies related to co-pay assistance programs

H.R. 1319 - American Rescue Plan Act of 2021; bill to provide additional relief to address continued impact of COVID-19 on the economy, public health, state and local governments, individuals, and businesses. H.R. 379/S. 104 - Improving Social Determinants of Health Act; bill to require the Centers for Disease Control and Prevention (CDC) to establish a program to improve health outcomes and reduce health inequities by, for example, coordinating activities across the CDC. As part of the program, the CDC must award grants to eligible organizations to build capacity to address social determinants of health. H.R. 469 - Comprehensive Breast Reconstruction Act of 2021; bill provides for Medicare, Medicaid, and private health insurance coverage of certain tattooing services in connection with post-mastectomy breast reconstruction, and aligns the scope of Medicare and Medicaid coverage of such breast reconstruction with that of private health insurance. Health disparities Clinical trial continuation Policies related to telehealth Policies related to COVID-19 vaccination distribution Policies to increase clinical trial diversity and access for underrepresented populations Comments to USPSTF on breast cancer screening Executive Orders related to insurance coverage Comments to White House on clinical trial continuation, health disparities, federal research investment, funding for NBCCEDP, SSDI and Medicare waiting periods, access to diagnostic imaging, and telehealth.

H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act H.R.8845/S.5051 - The Multi Cancer Early Detection Screening Coverage Act H.R. 913/S.4742 Clinical Treatment Act Medicare coverage policies for drugs and drug pricing Medicare coverage policy for breast cancer treatments and services Medicaid coverage and eligibility policies Proposed waivers under Sections 1115 and 1332 of the Social Security Act Proposed rule related to Securing Updated and Necessary Statutory Evaluations Timely Proposed rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency Proposed rules on Notice of Benefit and Payment Parameters Interim Final Rule on Most Favored Nation Policy Coverage for telemedicine in Medicare Radiation Oncology Alternative Payment Model 2021 Medicare Physician Fee Schedule Proposed Rule 2021 Medicare Hospital Outpatient Prospective Payment System Proposed Rule

FY21 National Defense Authorization Act (H.R.6395) - issues pertaining to the congressionally-directed medical research program, especially those relating the breast cancer

FY2021, Labor, HHS and Education Appropriations bill specifically pertaining to funding of biomedical research, NBCCEDP and related cancer services FY2021 funding for the DOD Breast Cancer Research Program H.R.113, Consolidated Omnibus Appropriations Act for program funding related to research, screening and treatment for breast cancer

FY2021, Labor, HHS and Education Appropriations bill specifically pertaining to funding of biomedical research, NBCCEDP and related cancer services FY2021 funding for the DOD Breast Cancer Research Program

Reauthorization of the Young Womens Breast Health Education and Awareness Requires Learning Young Act of 2009 by supporting the EARLY Act Reauthorization of 2020 (H.R.4078/S.2424) H.R.6337 - Health Equity and Accountability Act H.R.7308/S.4286 - Research Investment to Spark the Economy Act (RISE Act) Health disparities Clinical trial continuation Policies to increase clinical trial diversity Executive Orders related to insurance coverage and drug pricing FDA Office of Womens Health RFI Policies related to telehealth Policies related to COVID-19 vaccination distribution

FY21 National Defense Authorization Act (H.R.6395) - issues pertaining to the congressionally-directed medical research program, especially those relating the breast cancer

FY2021, Labor, HHS and Education Appropriations bill specifically pertaining to funding of biomedical research, NBCCEDP and related cancer services FY2021 funding for the DOD Breast Cancer Research Program

H.R.1370/S.562 - Breast Cancer Patient Equity Act H.R.1946/S.518 - Lymphedema Treatment Act H.R.2178/S.1374 - The Metastatic Breast Cancer Access to Care Act Medicare coverage policies for drugs and drug pricing Issues related to continued Medicaid coverage for high-quality, affordable health care Medicaid, Medicare and other policy changes due to the COVID-19 emergency Coverage for telemedicine in Medicare

FY21 National Defense Authorization Act - issues pertaining to the congressionally-directed medical research program, especially those relating the breast cancer

H.R.1730/S.741 - Cancer Drug Parity Act H.R.2428 - Access to Breast Cancer Diagnosis Act H.R.2777/S.1936 - Protecting Access to Lifesaving Screenings Act Supporting efforts to ensure those impact by breast cancer have access to high-quality, affordable health care: S.1895 - Lower Health Care Costs Act, H.R.986 - Protecting Americans with Preexisting Conditions Act, H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act, H.R.1010 - To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect, H.R.1884 - Protecting Pre-Existing Conditions and Making Health Care More Affordable Act Supporting provisions that increase patients' access to treatments: S.2543 - Prescription Drug Pricing Reduction Act, H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Efforts to reduce surprise medical billing

FY2020, Labor, HHS and Education Appropriations bill FY2020 funding for the DOD Breast Cancer Research Program

FY 2019 Department of Defense and Labor, Health and Human Services and Education Appropriations Bill - issues related to cancer prevention, screening and research funding.

Public Law 115-97 Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (tax reform)

H.R.2810/S.1519, National Defense Authorization Act, matters related to breast cancer research.

S.1771/H.R.3358: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H,R.3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Every and Water Development Appropriations Act, 2018

Public Law 114-223: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act, issues related to cancer prevention and research funding. FY2018 Labor-HHS-Education Appropriations, issues related to cancer prevention and research funding.